Edition:
United Kingdom

Intersect Ent Inc (XENT.OQ)

XENT.OQ on NASDAQ Stock Exchange Global Market

26.70USD
15 Aug 2018
Change (% chg)

$-0.35 (-1.29%)
Prev Close
$27.05
Open
$27.05
Day's High
$27.05
Day's Low
$26.15
Volume
70,049
Avg. Vol
72,855
52-wk High
$42.90
52-wk Low
$25.15

Chart for

About

Intersect ENT, Inc. is a commercial-stage drug-device company. The Company develops drugs for patients with ear, nose and throat (ENT) conditions. The Company has developed a drug releasing bioabsorbable implant technology that enables targeted and sustained release of therapeutic agents. This targeted drug delivery technology... (more)

Overall

Beta: --
Market Cap(Mil.): $894.66
Shares Outstanding(Mil.): 29.19
Dividend: --
Yield (%): --

Financials

  XENT.OQ Industry Sector
P/E (TTM): -- 32.29 32.76
EPS (TTM): -0.70 -- --
ROI: -16.93 13.92 14.61
ROE: -17.07 16.77 16.33

BRIEF-Intersect ENT Reports Qtrly Loss Per Share $0.21

* Q1 EARNINGS PER SHARE VIEW $-0.24 -- THOMSON REUTERS I/B/E/S

01 May 2018

BRIEF-Intersect ENT Q4 Revenue $29.5 Million

* INTERSECT ENT REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS

27 Feb 2018

Competitors

  Price Chg
Medtronic PLC (MDT.N) $90.99 -0.06

Earnings vs. Estimates